• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume7, Issue3

Quality Specification For Combined Action Suppositories With Benzetasone Content

    Umida M. Tillaeva

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 3292-3305

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

. Purpose is to conduct quality control and standardization methods of a combined action suppository containing benzketasone and papaya extract in accordance with modern requirements of good manufacturing practice.
Methods of natural and accelerated storage are used to study the factors affecting the stability of suppositories during storage (type of base used, temperature and storage time). It was revealed that under the conditions of a refrigerating chamber at a temperature of + 3-50 ° C, the studied suppositories practically did not change the quality indicators during 24 months of storage. The type of base slightly affected the change in the physicochemical parameters of the Benzpap and Benzpap 10 suppositories.
Keywords:
    Papaya suppositories drug forms pharmacy
  • PDF (387 K)
  • XML
(2020). Quality Specification For Combined Action Suppositories With Benzetasone Content. European Journal of Molecular & Clinical Medicine, 7(3), 3292-3305.
Umida M. Tillaeva. "Quality Specification For Combined Action Suppositories With Benzetasone Content". European Journal of Molecular & Clinical Medicine, 7, 3, 2020, 3292-3305.
(2020). 'Quality Specification For Combined Action Suppositories With Benzetasone Content', European Journal of Molecular & Clinical Medicine, 7(3), pp. 3292-3305.
Quality Specification For Combined Action Suppositories With Benzetasone Content. European Journal of Molecular & Clinical Medicine, 2020; 7(3): 3292-3305.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 32
  • PDF Download: 23
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus